Core Viewpoint - MindBio Therapeutics Corp. is developing an AI-driven edge computing platform for drug and alcohol intoxication detection, targeting large-scale deployment in the mining industry [1][4]. Group 1: Company Developments - The company is collaborating with an engineering firm to design and manufacture an integrated Edge AI solution for real-time voice analysis in remote environments, with prototype development nearing completion and field-ready deployment expected in Q2 2026 [2]. - The MindBio hardware device will be sold directly and through distribution channels, generating recurring revenue from the installed software for voice AI intoxication detection models [3]. - MindBio is pursuing enterprise-level commercialization opportunities, with initial deployment focused on the mining sector in South America, specifically in Chile [4]. Group 2: Market Opportunity - Studies indicate that over 75% of mining workers in Chile consume alcohol, with more than 40% classified as problem drinkers, highlighting a significant market opportunity for non-invasive intoxication detection technologies [6]. - Internationally, 20-25% of occupational accidents are linked to substance use, further emphasizing the need for scalable solutions in safety-critical industries [6]. Group 3: Technology and Innovation - The AI prediction model developed by MindBio utilizes over 50 million data points to accurately predict alcohol intoxication through voice analysis, with plans to expand its capabilities to other types of intoxication [8]. - Upon completion, the Edge AI platform is expected to support deployment across various safety-critical industries, including aviation and heavy industrial sectors, where current testing methods are invasive and costly [5].